A drug reduces cocaine and alcohol use in a small clinical trial
An experimental drug called mavoglurant can reduce the consumption of both cocaine and alcohol in people with cocaine use disorder, according to the results of a phase 2 clinical trial with 68 participants. Although trials with more participants are needed, the results suggest that this drug should be studied further. The findings, in which Spanish teams have participated, are published in the journal Science Translational Medicine.